Suit Against Renovaro Over Stock Resale Rights Trimmed By Court

Renovaro Biosciences Inc. must face part of a lawsuit from ex-majority shareholder Weird Science LLC claiming the biotech business breached an agreement to allow Weird Science to participate in certain sales of registered securities to the public.

Delaware Chancery Court Vice Chancellor Morgan T. Zurn trimmed Weird Science’s lawsuit in a bench ruling Wednesday.

• Weird Science’s contract breach claims that Renovaro—formerly known as Enochian Biosciences Inc.—failed to honor “piggyback” rights that Weird Science gained in a 2018 merger agreement can proceed, Zurn said
• The judge dismissed Weird Science’s fraudulent inducement claims as time-barred
• Zurn also dismissed Weird Science’s tortious interference ...